INV103:(X-Toll) pre-clinical results in lupus models
Strong pre-clinical data in lupus animal model (3 studies)
>significantly reduced kidney pathology
>improved survival
>prevented cutaneous lupus
>reduced renal and circulating levels of key pro-inflammatory mediators (TNF-a, IL-6 and MCP-1) reduced CD4+ T cells and auto-reactive T cells and increased the number of activated DC (critical in the establishment of self tolerance)
INV103:(X-Toll) pre-clinical results in lupus modelsStrong...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $25.69M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $5.78K | 1.445M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 12797949 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7472779 | 27 |
View Market Depth
| Last trade - 14.20pm 28/06/2024 (20 minute delay) ? |
| IVX (ASX) Chart |